Prognosis of patients with moderate and high-risk non-muscle-invasive bladder cancer treated with intravesical instillations of mitomycin C during unavailability of BCG vaccine

Abstract

The aim of this study is to evaluate the prognosis in patients with moderate and high-risk non-muscle-invasive bladder cancer treated with intravesical instillations of mitomycin C (MMC) during a period of unavailability of the BCG vaccine.

Keywords

• BCG vaccine
• instillation therapy
• intravesical chemotherapy
• mitomycin C
• bladder tumours